U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06843096) titled 'Contrast Enhanced Mammography in the Evaluation of Cancer of Unknown Primary Syndrome' on Feb. 14.
Brief Summary: This study aims to evaluate the role of Contrast-Enhanced Mammography (CEM) in identifying the primary tumor site in patients presenting with Cancer of Unknown Primary (CUP) syndrome. By integrating functional and anatomical imaging, the study explores CEM's diagnostic value compared to standard imaging modalities in a single-center setting.
Study Start Date: Jan. 01
Study Type: OBSERVATIONAL
Condition:
Breast Cancer Diagnosis
Breast Cancer Prevention
Intervention:
DIAGNOSTIC_TEST: Contrast-Enhanced Mammography (CE...